Intellia Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
BEAM
Beam Therapeutics Inc. |
$23.30 | $1.91 B | -14.51 | 472 | $377.71 M |
CRBU
Caribou Biosciences, Inc. |
$1.55 | $176.12 M | -1.41 | 158 | $34.48 M |
CRSP
CRISPR Therapeutics AG |
$38.36 | $4.91 B | -21.43 | 407 | $371.21 M |
DNA
Ginkgo Bioworks Holdings, Inc. |
$8.56 | $1.14 B | -1.2 | 1218 | $251.46 M |
EDIT
Editas Medicine, Inc. |
$1.14 | $435.86 M | -2.56 | 265 | $78.12 M |
FATE
Fate Therapeutics, Inc. |
$1.26 | $418.90 M | -1.92 | 181 | $63.53 M |
PRME
Prime Medicine, Inc. |
$2.71 | $788.60 M | -3.01 | 234 | $0 |
SANA
Sana Biotechnology, Inc. |
$3.63 | $1.55 B | -4.59 | 328 | $0 |
VERV
Verve Therapeutics, Inc. |
$5.27 | $409.24 M | -1.82 | 255 | $11.76 M |
VRTX
Vertex Pharmaceuticals Incorporated |
$411.69 | $124.65 B | 31.39 | 5400 | $9.87 B |